[Clinical evaluation of 2 years of hemodiafiltration using bicarbonate].
At the end of a previous study concerning the use of different buffers for hemodiafiltration (BHDF) in both the re-infusate (40 mM/L) and dialysate (26 mM/L). Retrospective data analysis and showed BHDF to permit good acid/base balance, good clinical tolerability and satisfactory and persistent sense of well-being. From the point of view of kinetics, it is essential to evaluate carefully the acute and/or chronic effect of an alkaline blood pH during or after dial lysis, especially since the volume distribution of bicarbonate is not known.
Petracca
E G
EG
Ospedale Civile di Rovigo.
Cesaro
A
A
Biasioli
S
S
D001639:Bicarbonates / Q000627:therapeutic use*; D015314:Dialysis Solutions / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D015312:Hemodialysis Solutions / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis
D001639:Bicarbonates; D015314:Dialysis Solutions; D015312:Hemodialysis Solutions
Valutazione clinica di 2 anni di emodiafiltrazione con bicarbonato.